e The amino acid sequences of one side of trastuzumab IgG and the... | Download Scientific Diagram
Sequence by MALDI and ESI of Herceptin and 5G4 mAb. The proteolytic... | Download Scientific Diagram
Sequence coverage obtained by CESI-MS/MS for trastuzumab (left-hand... | Download Scientific Diagram
CDR regions of Trastuzumab F(ab') 2 Light Chain and Heavy Chain Based... | Download Scientific Diagram
Frontiers | Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding
Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer | PLOS ONE
Trastuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab - RSC Advances (RSC Publishing) DOI:10.1039/C6RA04337B
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer | SpringerLink
Recombinant Anti-human ErbB2/HER2 Antibody (Trastuzumab) Conjugated with FITC
Cancers | Free Full-Text | T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer
Trastuzumab-Biosimilars Insight, 2022 - Research and Markets
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer
Frontiers | Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding
Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
A phosphorylation pattern-recognizing antibody specifically reacts to RNA polymerase II bound to exons | Experimental & Molecular Medicine
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo: Molecular Therapy
Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab - ScienceDirect
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali S - Adv Biomed Res
JCI Insight - CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis
Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin - ScienceDirect
Addgene: pVITRO1-Trastuzumab-IgM/κ
Multiple alignment of the trastuzumab amino acid sequence by ClustalW... | Download Scientific Diagram
Trastuzumab-dkst approval adds to the biosimilar cancer drug market | MDedge Hematology and Oncology
Sequence coverage of the heavy and light chains of... | Download Scientific Diagram
Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer | Nature Communications
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14) - The Lancet Gastroenterology & Hepatology
_[Trastuzumab_Biosimilar_2].png "JAN: Japanese Accepted Names for Pharmaceuticals")
JAN: Japanese Accepted Names for Pharmaceuticals
![Cancers | Free Full-Text | Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab](https://www.mdpi.com/cancers/cancers-15-02409/article_deploy/html/images/cancers-15-02409-g001.png "Cancers | Free Full-Text | Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab")
Cancers | Free Full-Text | Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
